Skip to main content

LCE 150 Pill: brown, oval, 15mm

The pill with imprint LCE 150 (Brown, Oval, 15mm) has been identified as Carbidopa, Entacapone and Levodopa 37.5 mg / 200 mg / 150 mg and is used for Parkinson's Disease. It belongs to the drug class dopaminergic antiparkinsonism agents and is not a controlled substance.

Images for LCE 150

Carbidopa, entacapone and levodopa 37.5 mg / 200 mg / 150 mg LCE 150 Front
Carbidopa, entacapone and levodopa 37.5 mg / 200 mg / 150 mg LCE 150 Back
Carbidopa, entacapone and levodopa 37.5 mg / 200 mg / 150 mg LCE 150

Carbidopa, Entacapone and Levodopa

Imprint
LCE 150
Strength
37.5 mg / 200 mg / 150 mg
Color
Brown
Size
15.00 mm
Shape
Oval
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sandoz Inc
Inactive Ingredients
corn starch, croscarmellose sodium, glycerin, hypromelloses, magnesium stearate, mannitol, polysorbate 80, povidone, sucrose, ferric oxide red, titanium dioxide, ferric oxide yellow

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00078-0409 (Discontinued) Novartis Pharmaceuticals Corporation
00781-5654 Sandoz Inc.

Get help with Imprint Code FAQs.

Related images for "LCE 150"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.